Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: Results from 4 UK centres

Radiotherapy and Oncology

Volumn 109, Issue 1, 2013, Pages 8-12

  Din, Omar S ^a   Harden, Susan V ^b   Hudson, Emma ^c   Mohammed, Nazia ^d   Pemberton, Laura S ^a   Lester, Jason F ^c   Biswas, Debashis ^b   Magee, Lavinia ^b   Tufail, Aisha ^d   Carruthers, Ross ^d   Sheikh, Ghazia ^d   Gilligan, David ^b   Hatton, Matthew Q F ^a  

^a WESTON PARK HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c VELINDRE CANCER CENTRE   (United Kingdom)

^d BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

Accelerated; Cancer; Hypofractionated; Lung; Radiotherapy

Indexed keywords

GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; DEMOGRAPHY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD REVIEW; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT IDENTIFICATION; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; TREATMENT PLANNING; UNITED KINGDOM;

ACCELERATED; CANCER; HYPOFRACTIONATED; LUNG; RADIOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; FEMALE; GREAT BRITAIN; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES;

EID: 84888026014     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.07.014     Document Type: Article

References (28)

1. GLOBOCAN 2008 (IARC) Section of Cancer Information (3/7/2011).
2. Available at: http://www.statistics.gov.uk/pdfdir/can1003.pdf, vol. 2007.
3. C.A. Perez, K. Stanley, and G. Grundy Impact of irradiation technique and tumour extent in tumour control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the radiation therapy oncology group Cancer 50 1982 1091 10995
4. M. Saunders, S. Dische, A. Barrett, A. Harvey, G. Griffiths, and M. Parmar Continuous, hyper-fractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial Radiother Oncol 52 1999 7
5. H.R. Withers, J.M. Taylor, and B. Maciejewski The hazard of accelerated tumour clonogen repopulation during radiotherapy Acta Oncol 27 1988 131 146
6. O.S. Din, J. Lester, and A. Cameron The routine use of Continuous, Hyper-fractionated, Accelerated Radiotherapy (CHART) for non-small cell lung cancer: a five centre experience Int J Radiat Oncol Biol Phys 72 2008 716 722
7. S.J. Clenton, P.M. Fisher, J. Conway, P. Kirkbride, and M.Q. Hatton The use of lung dose volume histograms in predicting post-radiation pneumonitis after non-conventionally fractionated radiotherapy for thoracic carcinoma Clin Oncol 17 2005 599 603
8. A. Price, A. Yellowlees, and S. Russell Radical Radiotherapy with or without Gemcitabine in patients with early stage medically inoperable non small cell lung cancer Lung Cancer 77 2012 532 536
9. J. Maguire, R. Mcmenemin, and N. O'Rourke A phase II trial of sequential chemotherapy verses concurrent chemotherapy and radiotherapy using an accelerated hypofractionated radiation schedule in stage III NSCLC J Thorac Oncol 5 2010 S558
10. L.S. Pemberton, O.S. Din, and P.M. Fisher Accelerated radical radiotherapy for non-small cell lung cancer using two common regimens: a single-centre retrospective study of outcome Clin Oncol 21 2009 161 167
11. J.F. Lester, F.R. Macbeth, and A.E. Brewster CT-planned accelerated hypofractionated radiotherapy in the radical treatment of non-small cell lung cancer Lung Cancer 45 2004 237 242
12. S.L. Faria, L. Souhami, and L. Portelance Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer Radiat Oncol 1 2006 42
13. P.C. Cheung, W.J. Mackillop, and P. Dixon Involved-field radiotherapy alone for early-stage non-small cell lung cancer Int J Radiat Oncol Biol Phys 48 2000 703 710
14. A. Chi, Z. Liao, and N.P. Nguyen Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications Radiother Oncol 94 2010 1 11
15. A. Munshi, S. Krishnatry, and S. Banerjee Stereotactic conformal radiotherapy in non small cell lung cancer - an overview Clin Oncol 24 2012 556 568
16. S. Senthi, F.J. Lagerwaard, C.J. Haasbeek, B.J. Slotman, and S. Senan Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis Lancet Oncol 13 2012 802 809
17. A. Baardwijk, W.A. Tome, and W. Elmpt Is high dose stereotactic body radiotherapy (SBRT) for stage I Non Small Cell lung Cancer (NSCLC) overkill? A systematic review Radiother Oncol 105 2012 145 149
18. Non-small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials BMJ 311 1995 899
19. A. Auperin, C. Le Pechoux, and J.P. Pignon Concomitant radio-chemotherapy based on platinum compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients Ann Oncol 17 2006 473 483
20. A. Auperin, C. Le Pechoux, and E. Rolland Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190
21. D. De Ruysscher, A. Botterweek, and M. Dirx Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective population-based study Ann Oncol 20 2009 98 102
22. C. Le Pechoux, A. Mauguen, and M. Baumann Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis J Clin Oncol 30 2012 2788 2797
23. M.Q. Hatton, M. Nankivell, and E.B. Lyn Induction chemotherapy and Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for patients with locally advanced inoperable non-small cell lung cancer: the MRC INCH randomised trial Int J Radiat Oncol Biol Phys 81 2011 712 718
24. C.P. Belani Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyper-fractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer J Clin Oncol 23 2005 3760 3767
25. M. Baumann, T. Herrmann, and R. Koch Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC) Radiother Oncol 100 2011 76 85
26. J. Belderbos, L. Uitterhoeve, N. Van Zandwijk on behalf of the EORTC LCG and RT Group Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973) Eur J Cancer 43 2007 114 121
27. P. Thirion, O. Holmberg, and C.D. Collins Escalated dose for non-small cell lung cancer with accelerated hypofractionated three dimensional conformal radiation therapy Radiother Oncol 71 2011 163 166
28. J. Belderbos, K. De Jeager, and W. Heemsbergen Final results of a phase I/II dose escalation trial in non small cell lung cancer using three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 66 2006 126 134